SELE and COVID-19: Higher circulating levels of soluble VCAM-1 and E-selectin have been reported in patients with COVID-19, and are associated with elevated levels of pro-inflammatory cytokines and chemokines such as tumor necrosis factor-α (TNF-α), indicating endothelial injury [19,20,21,22].